Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tablet.
Gotoh M, Okubo K, Yuta A, Ogawa Y, Nagakura H, Ueyama S, Ueyama T, Kawashima K, Yamamoto M, Fujieda S, Sakashita M, Sakamoto H, Iwasaki N, Mori E, Endo T, Ohta N, Kitazawa H, Okano M, Asako M, Takada M, Terada T, Inaka Y, Yonekura S, Matsuoka T, Kaneko S, Hata H, Hijikata N, Tanaka H, Masuyama K, Okamoto Y.
Gotoh M, et al. Among authors: masuyama k.
Allergol Int. 2020 Jan;69(1):104-110. doi: 10.1016/j.alit.2019.07.007. Epub 2019 Aug 14.
Allergol Int. 2020.
PMID: 31421989
Free article.
Clinical Trial.